Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex
Open Access
- 8 September 2017
- journal article
- case report
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 8, 469
Abstract
Background | Recent studies indicate excitatory GABA action in and around tubers in patients with Tuberous Sclerosis Complex (TSC). This may contribute to recurrent seizures and behavioral problems that may be treated by agents that enhance GABAergic transmission by influencing chloride regulation. Case presentation | Here, we used the chloride transporter antagonist bumetanide to treat a female adolescent TSC patient with refractory seizures, sensory hyper-reactivity and a variety of repetitive and compulsive behaviors. Methods | To evaluate the effect of bumetanide on behavior, auditory sensory processing and hyperexcitability, we obtained questionnaire data, event-related potentials (ERP) and resting state EEG at baseline, after three and six months of treatment and after one month washout period. Discussion | Six months of treatment resulted in a marked improvement in all important behavioral domains, as was substantiated by significant changes reported in parent questionnaires. In addition, resting-state electroencephalography and event-related potentials suggested a favorable effect of bumetanide on hyperexcitability and sensory processing. These findings encourage further studies into the potential benefit of bumetanide on the neuropsychiatric outcome of TSC.Keywords
This publication has 24 references indexed in Scilit:
- Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesionsNeurobiology of Disease, 2016
- Paradoxical Benzodiazepine Response: A Rationale for Bumetanide in Neurodevelopmental Disorders?Pediatrics, 2015
- Neurological and neuropsychiatric aspects of tuberous sclerosis complexThe Lancet Neurology, 2015
- Tuberous Sclerosis Associated Neuropsychiatric Disorders (TAND) and the TAND ChecklistPediatric Neurology, 2015
- The effect of bumetanide treatment on the sensory behaviours of a young girl with Asperger syndromeBMJ Case Reports, 2014
- A randomised controlled trial of bumetanide in the treatment of autism in childrenTranslational Psychiatry, 2012
- Altered inhibition in tuberous sclerosis and type IIb cortical dysplasiaAnnals of Neurology, 2011
- Targeted Treatments for Cognitive and Neurodevelopmental Disorders in Tuberous Sclerosis ComplexNeurotherapeutics, 2010
- Topical Review : Neuropsychiatric Problems in Tuberous Sclerosis ComplexJournal of Child Neurology, 2004
- Validation of a Brief Quantitative Measure of Autistic Traits: Comparison of the Social Responsiveness Scale with the Autism Diagnostic Interview-RevisedJournal of Autism and Developmental Disorders, 2003